September 2026
riboLASSO is now open for pilot access. Bead-free, enzyme-free rRNA depletion, ready to test in your own RNA-seq workflow.
Request a pilot kit or explore riboLASSO to learn more.
May 2026
After many many iterations, we are proud to have launched our first pilot kits.
Explore our products to get access to our Ready-to-use kits and Minimal Discovery kits.
Feb 2026- May 2026
Dynamic Matrices attended the 12-week boOst startup incubator.
This 12-week incubator program, held across 3 cities, helped us focus on revenue, find paying customers, build a team & collect further funding. Together with partners from the industry and entrepreneurs, we cherished a high paced environment for feedback, constant coaching and iteration.
April 2026
Dynamic Matrices has been awarded a Translational Research Fund by Leibniz Health Technologies, supporting the development and commercialization of LASSO. This funding marks a key milestone in our transition from academic research to market-ready biotechnology.
April 2025
Dynamic Matrices has been awarded an EXIST-Forschungstransfer grant by the German Federal Ministry for Economic Affairs, supporting the development and commercialization of DyNAtrix. This funding marks a key milestone in our transition from academic research to market-ready biotechnology.
